Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]
Wave Life Sciences (NASDAQ:WVE)
Recent Posts
BLUE WATER PETROLEUM LAUNCHES ITS THERMO VARNISH PRODUCT
Metatron Releases Chat-GPT4 Powered AI Content Mobile Apps
ChatGPT4-powered AI Content Mobile Applications
Better Carbon Offsets With AI: How Arma’s Innovative Artificial Intelligence Technology Can Create Offsets With More Accuracy and Value
Winners Creates Another New Expected Revenue Stream – Signs Terms Sheet With “Horse Races Now” and “Next Play Digital”
Popular Post
-
InnerScope Hearing Technologies (OTC: INND) Launches HearingAssist Brand of FDA-Registered OTC Rechargeable Hearing Aids on Target.com
-
Sports Gambling and the Horse Racing Market
-
ZICIX+CTIP-FII RECEIVES NOTICE TO PROCEED FROM PROJECT OWNER TO START THE $20 MILLION SENIOR CITIZENS RESIDENCE PROJECT IN NEWARK, NEW JERSEY
-
Principal Solar to Acquire Minerva-Rockdale Leases, Wells, and Assets
-
Kona Gold Beverage, Inc Announces its Ooh La Lemin Lemonades to be sold in Town Pump Convenience Stores in Montana
